Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Procedure
  • Participants: 20
  • Start Date: January 2021
Beyond Analysis Of Blood Sample, to Approach Immunopathology of Polymyalgia Rheumatica on Shoulder Bursae's Biopsies: the BAOBAB Study
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 34
  • Start Date: December 1, 2020
BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica (BACHELOR Study)
Search for trials
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 143
  • Start Date: September 14, 2020
Improved Diagnostics and Monitoring of Polymyalgia Rheumatica
Clinical Trial
  • Status: Recruiting
  • Participants: 5000
  • Start Date: August 4, 2020
Rheumatology Patient Registry and Biorepository
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other
  • Participants: 4000
  • Start Date: March 2020
The Epidemiology, Management, and the Associated Burden of Mental Health, Atopic and Autoimmune Conditions in Alopecia Areata
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 15
  • Start Date: August 31, 2019
Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 72
  • Start Date: June 27, 2019
Safety, Activity, and Pharmacology of Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 25
  • Start Date: June 25, 2019
The PET Imaging of Giant Cell and Takayasu Arteritis Study
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 94
  • Start Date: March 1, 2019
A Multicenter Randomized Placebo Controlled Treatment Study of Leflunomide in Polymyalgia Rheumatica
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 30
  • Start Date: November 28, 2018
Tocilizumab Plus a Short Prednisone Taper for Giant Cell Arteritis (GCA)
Showing 1-12 of 13